Pharmaceuticals

Premium

Healthcare

27 May, 2024

Searchlight: Emnar Pharma poised to turn around after a decline in FY23 financials

Emnar Pharma Pvt. Ltd (formerly Emmennar Pharma), a part of the Virchow group, is likely to see a rebound in ......

Premium

Healthcare

15 May, 2024

Bottomline: How PlasmaGen Bio plans to break its streak of revenue stagnancy

Bengaluru-based biopharmaceutical company PlasmaGen Biosciences Pvt. Ltd, backed by venture capital firm Eight Roads ......

Premium

Healthcare

30 April, 2024

Exclusive: Advent's healthcare investment platform mulls betting on south Indian API maker

Advent, one of the world’s biggest private equity players, is evaluating an investment in a Chennai-based active ......

Premium

Healthcare

25 April, 2024

Searchlight: TCG Lifesciences' topline may take hit on slowing ops in subsidiaries

TCG Lifesciences Pvt. Ltd, a part of The Chatterjee Group, may record a weaker performance for the year ended March ......

Premium

Healthcare

10 April, 2024

KKR-controlled JB Chemicals draws interest from PE firms, drugmakers

A clutch of suitors including pharmaceutical companies and bulge-bracket private equity firms have shown interest in ......

Premium

Healthcare

29 February, 2024

Former Biocon execs' CRAMS firm Anthem Bio eyes pre-IPO funding

Bengaluru-based pharma contract research company Anthem Biosciences Pvt. Ltd, which hit the billion-dollar valuation ......

Premium

Healthcare

25 January, 2024

Bottomline: Affirma-backed nutraceuticals maker Tirupati's financial see-saw continues

Neutraceuticals maker Tirupati Medicare recorded a hit in operational margin in FY23 after fluctuations last fiscal, ......

Premium

Healthcare

19 January, 2024

Bottomline: InvAscent-backed Symbiotec has struggled to break out; will FY25 be different?

Homegrown corticosteroid and hormones API-maker Symbiotec Lifesciences Pvt. Ltd’s revenue and profitability took a hit......

Premium

Healthcare

03 January, 2024

Kotak's second special situations PE fund bankrolling big-ticket pharma acquisition

Kotak Alternate Asset Managers (previously Kotak Investment Advisors), the alternative investment arm of Kotak Group, ......

Premium

Healthcare

20 December, 2023

Bain Capital tweaks exit plan from decade-old India portfolio company

American private equity firm Bain Capital, which has been particularly active in India this year having struck three new......

Most Popular

Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News